Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if choline bitartrate can be administered daily to
children with prenatal alcohol exposure, ages 2.5 to 5, as a potential treatment for brain
development and cognitive functioning.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)